Showing results (101-110 of 3,361) with videos related to
Sort By:
Pageof 337
European Journal of Clinical Microbiology|April 1, 1987
Comparative in vitro activity of amifloxacin and five other fluoroquinolone antimicrobial agents and preliminary criteria for the disk susceptibility testA L Barry, R N JonesJournal of Clinical Microbiology|November 1, 1987
Disk diffusion susceptibility testing and broth microdilution quality control guidelines for BMY-28100, a new orally administered cephalosporinR N Jones, A L BarryDiagnostic Microbiology and Infectious Disease|November 1, 1989
Studies to optimize the in vitro testing of piperacillin combined with tazobactam (YTR 830)R N Jones, A L BarryDiagnostic Microbiology and Infectious Disease|January 1, 1988
BMY-28100, a new oral cephalosporin: antimicrobial activity against nearly 7,000 recent clinical isolates, comparative potency with other oral agents, and activity against beta-lactamase producing isolatesR N Jones, A L BarryDiagnostic Microbiology and Infectious Disease|May 1, 1987
Antimicrobial activity of coumermycin and recommendations for disk diffusion tests with 5- and 15-micrograms disksR N Jones, A L BarryJournal of Clinical Microbiology|January 1, 1976
Comparison of amino acid decarboxylase and dihydrolase results by Moeller, rapid, and replicator plate methodsR N Jones, P C Fuchs, S SnidermanJournal of Clinical Microbiology|February 1, 1978
Multiple-inocula (replicator) CAMP test for presumptive identification of group B streptococciP C Fuchs, C Christy, R N JonesThe Journal of Antibiotics|January 1, 1979
Piperacillin (T-1220), a new semisynthetic penicillin. II. In vitro antimicrobial activity and synergy comparison with carbenicillin and gentamicinR N Jones, R R Packer, A L Barry, et al.Diagnostic Microbiology and Infectious Disease|April 1, 1986
In vitro activity of DJ-6783 (a keto carboxylic acid) compared with six other orally administered antimicrobial agentsR N Jones, L W Ayers, A L Barry, et al.Diagnostic Microbiology and Infectious Disease|May 1, 1987
RO 23-6240 (AM-833), a new fluoroquinolone: in vitro antimicrobial activity and tentative disk diffusion interpretive criteriaP C Fuchs, R N Jones, A L Barry, et al.Pageof 337